Standout Papers

Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease 2021 2026 2022 2024250
  1. Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease (2021)
    Robert Zeiser, Nicola Polverelli et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 26 standout
Sub-graph 1 of 12

Citing Papers

An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
NF-κB in biology and targeted therapy: new insights and translational implications
2024 Standout
2 intermediate papers

Works of Ant Uzay being referenced

Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease
2021 Standout

Author Peers

Author Last Decade Papers Cites
Ant Uzay 235 96 121 21 410
Bachra Choufi 276 100 133 24 457
Xavier Cahu 219 108 145 22 408
Michihiko Masuda 170 79 113 26 362
Laurent Pascal 267 81 133 24 426
B. Dörken 108 84 97 22 381
Jan‐Erik Johansson 170 122 117 29 443
G. P. Clein 112 100 73 12 388
Fumiaki Yoshiba 154 122 198 21 451
Francesco Grimaldi 161 110 120 29 449
JF Tomás 277 45 92 17 360

All Works

Loading papers...

Rankless by CCL
2026